======= ID4 ======= == Gene Information == * **Official Symbol**: ID4 * **Official Name**: inhibitor of DNA binding 4, HLH protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3400|3400]] * **UniProt**: [[https://www.uniprot.org/uniprot/P47928|P47928]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ID4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ID4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600581|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation (By similarity). {ECO:0000250}. |HLH| |seminal vesicle morphogenesis| |prostate gland stromal morphogenesis| |seminal vesicle development| |negative regulation of astrocyte differentiation| |negative regulation of oligodendrocyte differentiation| |central nervous system myelination| |axon ensheathment in central nervous system| |prostate gland epithelium morphogenesis| |prostate gland morphogenesis| |cerebral cortex neuron differentiation| |negative regulation of glial cell differentiation| |regulation of astrocyte differentiation| |neuroblast proliferation| |regulation of oligodendrocyte differentiation| |negative regulation of gliogenesis| |prostate gland development| |oligodendrocyte development| |negative regulation of fat cell differentiation| |stem cell proliferation| |negative regulation of DNA binding| |RNA polymerase II transcription factor binding| |oligodendrocyte differentiation| |regulation of glial cell differentiation| |neural precursor cell proliferation| |hippocampus development| |gland morphogenesis| |fat cell differentiation| |myelination| |glial cell development| |axon ensheathment| |ensheathment of neurons| |limbic system development| |regulation of gliogenesis| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |regulation of fat cell differentiation| |regulation of DNA binding| |osteoblast differentiation| |circadian rhythm| |protein dimerization activity| |negative regulation of binding| |glial cell differentiation| |pallium development| |central nervous system neuron differentiation| |gliogenesis| |connective tissue development| |negative regulation of neuron differentiation| |transcription corepressor activity| |telencephalon development| |ossification| |mitotic cell cycle phase transition| |rhythmic process| |cell cycle phase transition| |negative regulation of neurogenesis| |negative regulation of nervous system development| |urogenital system development| |transcription factor binding| |negative regulation of cell development| |regulation of binding| |forebrain development| |gland development| |reproductive structure development| |reproductive system development| |morphogenesis of an epithelium| |cell population proliferation| |tissue morphogenesis| |mitotic cell cycle process| |regulation of neuron differentiation| |developmental process involved in reproduction| |DNA-binding transcription factor activity| |mitotic cell cycle| |negative regulation of cell differentiation| |brain development| |head development| |regulation of neurogenesis| |negative regulation of transcription by RNA polymerase II| |positive regulation of cell population proliferation| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |animal organ morphogenesis| |central nervous system development| |cell cycle process| |neuron differentiation| |epithelium development| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular protein localization| |cellular macromolecule localization| |regulation of cell population proliferation| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|1.76| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|1.79| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.86| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.88| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.1| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.13| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.14| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|2.2| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.25| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|2.33| |[[:results:exp67|BVD-523 15μM R02 exp67]]|2.38| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|2.66| ^Gene^Correlation^ |[[:human genes:i:id3|ID3]]|0.501| |[[:human genes:n:nsd1|NSD1]]|0.432| |[[:human genes:f:fbxo11|FBXO11]]|0.419| |[[:human genes:r:runx1|RUNX1]]|0.405| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12968 * **Expression level (log2 read counts)**: 4.46 {{:chemogenomics:nalm6 dist.png?nolink |}}